R&D
Advancing Pharmaceutical Excellence Since 2020
Kaifeng Darui Pharmaceutical Co., Ltd., a high-tech enterprise established in 2020, specializes in the R&D, production, and distribution of premium veterinary APIs, food additives, and pharmaceutical intermediates. With a registered capital of ¥27 million and rapid growth (2024 output: ¥60M+, tax contribution: ¥2M+), we combine scientific rigor with sustainable practices to redefine industry standards.
Core R&D Capabilities
1. State-of-the-Art Infrastructure
- GMP-Certified Facilities: Designed per China’s Veterinary Drug Production Quality Management norms, featuring:
- D-grade cleanrooms with independent air purification systems
- 700㎡ API production area (synthesis + refining/packaging)
- Advanced equipment: precision distillation units, 150t/d wastewater treatment, RCO exhaust systems
2. Cutting-Edge Analytical Capabilities
Our labs leverage world-class instrumentation for quality assurance:
- Chromatography: Shimadzu HPLC, Yichun GC, Fourier-transform IR
- Precision Tools: UV-Vis spectrophotometers, electronic analytical balances, stability test chambers
3. Expert-Led Innovation
- 20+ specialized researchers (20% of workforce), including 2 professors and 4 senior engineers
- University collaborations: Henan Academy of Chemical Sciences, Pingdingshan University
- Active patent portfolio: 12 utility patents (e.g., bromonitro alcohol yield enhancement systems) + 4 pending
Strategic Industry Leadership
Key Achievements
- 2023 High-Tech Enterprise Certification (Henan Province)
- 2022 Innovative SME Award
- 18 GMP Certificates for veterinary APIs (issued Nov 2024)
Market-Focused Development
- Pet Healthcare Solutions: Developing antiparasitics (e.g., albendazole derivatives) and antiviral APIs
- Global Expansion: Cost-competitive API exports with rising international recognition
- 3-Year Roadmap: Targeting ¥100M output by 2025, doubling R&D investment to ¥20M
Sustainable Growth Philosophy
Guided by our motto “Quality for Survival, Talent for Foundation; Science for Growth, Management for Efficiency,” we prioritize:
- Green Chemistry: Closed-loop systems for solvent recovery and low-waste synthesis
- Talent Cultivation: 70%+ staff with tertiary education in specialized training programs
- Community Impact: 2023 “Charitable Enterprise” honoree for social responsibility initiatives
Why Partner with Darui Pharma?
- End-to-End Expertise: From molecular design to scaled GMP production
- IP-Protected Solutions: Customizable intermediates like brominated alkanes and chlorobenzamide derivatives
- Regulatory Mastery: Full compliance with veterinary medicine and food additive regulations
Contact Us to explore API development, technology transfers, or custom synthesis projects.
.jpg)